Emily Bremers

Emily Bremers

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2018 in International Journal of STEM Education
Verified
Journal Article
Open access
PDF file
MDMary F. Durham
Mary F. Durham
JKJennifer K. Knight
Jennifer K. Knight
EBEmily Bremers
Emily Bremers
JDJameson D. DeFreece
Jameson D. DeFreece
APAlex R. Paine
Alex R. Paine
BCBrian A. Couch
Brian A. Couch
The Scientific Teaching (ST) pedagogical framework encompasses many of the best practices recommended in the literature and highlighted in national reports. Understanding the growth and impact of ST requires instruments to accurately measure the extent to which practitioners implement ST in their courses. Researchers have typically relied on students, instructors, or observers to document course teaching practices, but it remains unclear whether and how these perspectives differ from each other. To address this issue, we modified our previously published instrument to generate the Measurement Instrument for Scientific Teaching-Observable (MISTO), which can be completed by students, instructors, and observers, and we investigated the degree of similarity between these three perspectives across 70 undergraduate science courses at seven different institutions in the USA. We found that the full MISTO and Active Learning subcategory scores showed the highest correlations among the three perspectives, but the degree of correlation between perspectives varied for the other subcategories. Match scores between students and instructors were significantly higher than observer matches for the full MISTO and for the Active Learning, Inclusivity, and Responsiveness subcategories. We find that the level and type of agreement between perspectives varies across MISTO subcategories and that this variation likely stems from intrinsic differences in the course access and scoring decisions of the three perspectives. Building on this data, we recommend MISTO users consider their research goals, available resources, and potential artifacts that may arise when deciding which perspective best fits their needs in measuring classroom teaching practices.

24 February 2022 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
HAHanan Almolhim
Hanan Almolhim
SDSha Ding
Sha Ding
JBJoshua H. Butler
Joshua H. Butler
EBEmily Bremers
Emily Bremers
GBGrant J. Butschek
Grant J. Butschek
PCPaul R. Carlier
Paul R. Carlier

13 March 2023 in Molecules
Verified
Journal Article
Open access
PDF file
JBJoshua H. Butler
Joshua H. Butler
HPHeather Painter
Heather Painter
EBEmily Bremers
Emily Bremers
PKPriscilla Krai
Priscilla Krai
MLManuel Llinás
Manuel Llinás
MCMaria Belen Cassera
Maria Belen Cassera
Cripowellins from Crinum erubescens are known pesticidal and have potent antiplasmodial activity. To gain mechanistic insights to this class of natural products, studies to determine the timing of action of cripowellins within the asexual intraerythrocytic cycle of Plasmodium falciparum were performed and led to the observation that this class of natural products induced reversible cytostasis in the ring stage within the first 24 h of treatment. The transcriptional program necessary for P. falciparum to progress through the asexual intraerythrocytic life cycle is well characterized. Whole transcriptome abundance analysis showed that cripowellin B “pauses” the transcriptional program necessary to progress through the intraerythrocytic life cycle coinciding with the lack of morphological progression of drug treated parasites. In addition, cripowellin B-treated parasites re-enter transcriptional progression after treatment was removed. This study highlights the use of cripowellins as chemical probes to reveal new aspects of cell cycle progression of the asexual ring stage of P. falciparum which could be leveraged for the generation of future antimalarial therapeutics.

28 October 2024 in ACS Infectious Diseases
Verified
Journal Article
Closed access
JMJopaul Mathew
Jopaul Mathew
BZBo Zhou
Bo Zhou
RHReagan S. Haney
Reagan S. Haney
KKKevin A. Kunz
Kevin A. Kunz
LALeticia S. Do Amaral
Leticia S. Do Amaral
PCPaul R. Carlier
Paul R. Carlier

14 January 2025 in ACS Infectious Diseases
Verified
Journal Article
Open access
EBEmily Bremers
Emily Bremers
JBJoshua H. Butler
Joshua H. Butler
LALeticia S. Do Amaral
Leticia S. Do Amaral
EMEmilio F. Merino
Emilio F. Merino
HAHanan Almolhim
Hanan Almolhim
MCMaria Belen Cassera
Maria Belen Cassera
Half the world's population is at risk of developing a malaria infection, which is caused by parasites of the genus Plasmodium. Currently, resistance has been identified to all clinically available antimalarials, highlighting an urgent need to develop novel compounds and better understand common mechanisms of resistance. We previously identified a novel tetrahydro-beta-carboline compound, PRC1590, which potently kills the malaria parasite. To better understand its mechanism of action, we selected for and characterized resistance to PRC1590 in Plasmodium falciparum. Through in vitro selection of resistance to PRC1590, we have identified that a single-nucleotide polymorphism on the parasite's multidrug resistance protein 1 (PfMDR1 G293V) mediates resistance to PRC1590. This mutation results in stereospecific resistance and sensitizes parasites to other antimalarials, such as mefloquine, quinine, and MMV019017. Intraerythrocytic asexual stage specificity assays have revealed that PRC1590 is most potent during the trophozoite stage when the parasite forms a single digestive vacuole (DV) and actively digests hemoglobin. Moreover, fluorescence microscopy revealed that PRC1590 disrupts the function of the DV, indicating a potential molecular target associated with this organelle. Our findings mark a significant step in understanding the mechanism of resistance and the mode of action of this emerging class of antimalarials. In addition, our results suggest a potential link between resistance mediated by PfMDR1 and PRC1590's molecular target. This research underscores the pressing need for future research aimed at investigating the intricate relationship between a compound's chemical scaffold, molecular target, and resistance mutations associated with PfMDR1.

27 April 2026 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
BZBo Zhou
Bo Zhou
LALeticia S. Do Amaral
Leticia S. Do Amaral
EBEmily Bremers
Emily Bremers
RHReagan S. Haney
Reagan S. Haney
LWLyric A. Wardlaw
Lyric A. Wardlaw
PCPaul R. Carlier
Paul R. Carlier